These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23881704)

  • 1. A commentary on iPS cells: potential applications in autologous transplantation, study of illnesses and drug screening.
    Romano G; Morales F; Marino IR; Giordano A
    J Cell Physiol; 2014 Feb; 229(2):148-52. PubMed ID: 23881704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced pluripotent stem cell research: a revolutionary approach to face the challenges in drug screening.
    Song M; Paul S; Lim H; Dayem AA; Cho SG
    Arch Pharm Res; 2012 Feb; 35(2):245-60. PubMed ID: 22370779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An introduction to induced pluripotent stem cells.
    Hanley J; Rastegarlari G; Nathwani AC
    Br J Haematol; 2010 Oct; 151(1):16-24. PubMed ID: 20666774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translational prospects for human induced pluripotent stem cells.
    Csete M
    Regen Med; 2010 Jul; 5(4):509-19. PubMed ID: 20632855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of induced pluripotent stem cells into functional oligodendrocytes.
    Czepiel M; Balasubramaniyan V; Schaafsma W; Stancic M; Mikkers H; Huisman C; Boddeke E; Copray S
    Glia; 2011 Jun; 59(6):882-92. PubMed ID: 21438010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncertain translation, uncertain benefit and uncertain risk: ethical challenges facing first-in-human trials of induced pluripotent stem (ips) cells.
    Fung RK; Kerridge IH
    Bioethics; 2013 Feb; 27(2):89-96. PubMed ID: 21726264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced pluripotent stem cells: a new technology to study human diseases.
    Vitale AM; Wolvetang E; Mackay-Sim A
    Int J Biochem Cell Biol; 2011 Jun; 43(6):843-6. PubMed ID: 21458591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced pluripotent stem cells (iPSCs)--a new era of reprogramming.
    Kang L; Kou Z; Zhang Y; Gao S
    J Genet Genomics; 2010 Jul; 37(7):415-21. PubMed ID: 20659705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A challenge towards the clinical application of induced pluripotent stem cell technology for the treatment of Parkinson's disease].
    Morizane A; Takahashi J
    Brain Nerve; 2012 Jan; 64(1):29-37. PubMed ID: 22223499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Future perspective of induced pluripotent stem cells for diagnosis, drug screening and treatment of human diseases.
    Lian Q; Chow Y; Esteban MA; Pei D; Tse HF
    Thromb Haemost; 2010 Jul; 104(1):39-44. PubMed ID: 20539907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficient generation of induced pluripotent stem (iPS) cells from adult mouse adipose tissue-derived and neural stem cells.
    Tat PA; Sumer H; Jones KL; Upton K; Verma PJ
    Cell Transplant; 2010; 19(5):525-36. PubMed ID: 20144262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. iPS cell technology in regenerative medicine.
    Lengner CJ
    Ann N Y Acad Sci; 2010 Mar; 1192():38-44. PubMed ID: 20392216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human induced pluripotent stem cells: a review of the US patent landscape.
    Georgieva BP; Love JM
    Regen Med; 2010 Jul; 5(4):581-91. PubMed ID: 20632861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances and applications of induced pluripotent stem cells.
    Pietronave S; Prat M
    Can J Physiol Pharmacol; 2012 Mar; 90(3):317-25. PubMed ID: 22364544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of clinically relevant "induced pluripotent stem" (iPS) cells.
    Heffernan C; Sumer H; Verma PJ
    J Stem Cells; 2011; 6(3):109-27. PubMed ID: 23264997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Research for cell therapy by induced pluripotent stem cell].
    Sakurai H; Yamanaka S
    Nihon Rinsho; 2011 Dec; 69(12):2114-8. PubMed ID: 22242307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced pluripotent stem cells.
    Bhowmik S; Li Y
    Chin Med J (Engl); 2011 Jun; 124(12):1897-900. PubMed ID: 21740850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induced pluripotent stem cells and promises of neuroregenerative medicine.
    Verma A; Verma N
    Neurol India; 2011; 59(4):555-7. PubMed ID: 21891933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory considerations for the development of autologous induced pluripotent stem cell therapies.
    Carpenter MK; Couture LA
    Regen Med; 2010 Jul; 5(4):569-79. PubMed ID: 20632860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced pluripotent stem cells: a new approach for physiological research.
    Pfannkuche K; Hannes T; Khalil M; Noghabi MS; Morshedi A; Hescheler J; Dröge P
    Cell Physiol Biochem; 2010; 26(2):105-24. PubMed ID: 20798495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.